{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:57:02Z","timestamp":1786625822077,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Beijing Science and Technology Plan","award":["Z151100004015172"],"award-info":[{"award-number":["Z151100004015172"]}]},{"name":"Beijing Natural Science Fund","award":["7132087"],"award-info":[{"award-number":["7132087"]}]},{"name":"Public Health Project of Science and Technology Committee of the Beijing Municipal Development projects","award":["Z131100006813041"],"award-info":[{"award-number":["Z131100006813041"]}]},{"name":"Medical Development Research Foundation of the Capital, China","award":["2014-4-2025"],"award-info":[{"award-number":["2014-4-2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13045-016-0317-7","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T10:55:26Z","timestamp":1473418526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["PEG-aspargase and DEP regimen combination therapy for refractory Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1186","volume":"9","author":[{"given":"Jingshi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"issue":"2","key":"317_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rmv.638","volume":"20","author":"NR Maakaroun","year":"2010","unstructured":"Maakaroun NR, Moanna A, Jacob JT, Albrecht T. Viral infections associated with haemophagocytic syndrome. Rev Med Virol. 2010;20(2):93\u2013105.","journal-title":"Rev Med Virol"},{"issue":"6","key":"317_CR2","first-page":"507","volume":"36","author":"X Zeng","year":"2015","unstructured":"Zeng X, Wei N, Wang Y, Wang J, Zhang J, Wu L, et al. Treatment outcomes and prognostic analysis of 61 Epstein\u2013Barr virus-associated hemophagocytic lymphohistiocytosis. Zhonghua Xue Ye Xue Za Zhi. 2015;36(6):507\u201310 (Article in Chinese).","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"7","key":"317_CR3","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Aric\u00f3 M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100(7):2367\u201373.","journal-title":"Blood"},{"issue":"2","key":"317_CR4","first-page":"183","volume":"89","author":"S Imashuku","year":"2004","unstructured":"Imashuku S, Teramura T, Tauchi H, Ishida Y, Otoh Y, Sawada M, et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica. 2004;89(2):183\u20138.","journal-title":"Haematologica"},{"issue":"3","key":"317_CR5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386.","journal-title":"Blood"},{"issue":"19","key":"317_CR6","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","volume":"126","author":"Y Wang","year":"2015","unstructured":"Wang Y, Huang W, Hu L, Cen X, Li L, Wang J, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126(19):2186\u201392.","journal-title":"Blood"},{"issue":"2","key":"317_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"317_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","volume":"44","author":"S Imashuku","year":"2002","unstructured":"Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44(3):259\u201372.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"317_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","volume":"60","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with Alemtuzumab. Pediatr Blood Cancer. 2013;60(1):101\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"317_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.24039","volume":"59","author":"A Shiraishi","year":"2012","unstructured":"Shiraishi A, Ohga S, Doi T, Ishimura M, Takimoto T, Takada H, et al. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012;59(2):265\u201370.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"317_CR11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0029-1237386","volume":"221","author":"G Janka","year":"2009","unstructured":"Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221(5):278\u201385.","journal-title":"Klin Padiatr"},{"issue":"2","key":"317_CR12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pbc.22037","volume":"53","author":"K Beutel","year":"2009","unstructured":"Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer. 2009;53(2):184\u201390.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"317_CR13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/653424","volume":"51","author":"CP Fox","year":"2010","unstructured":"Fox CP, Shannon-Lowe C, Gothard P, Kishore B, Neilson J, O\u2019Connor N, et al. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells. Clin Infect Dis. 2010;51(1):66\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"317_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol. 2001;1(1):75\u201382.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"317_CR15","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","volume":"19","author":"S Imashuku","year":"2001","unstructured":"Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19(10):2665\u201373.","journal-title":"J Clin Oncol"},{"issue":"2","key":"317_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mpo.10314","volume":"41","author":"S Imashuku","year":"2003","unstructured":"Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol. 2003;41(2):103\u20139.","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"317_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pbc.22310","volume":"54","author":"S Ohga","year":"2010","unstructured":"Ohga S, Kudo K, Ishii E, Honjo S, Morimoto A, Osugi Y, et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer. 2010;54(2):299\u2013306.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"317_CR18","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.2006-3164","volume":"120","author":"N Mahlaoui","year":"2007","unstructured":"Mahlaoui N, Ouach\u00e9e-Chardin M, de Saint Basile G, Neven B, Picard C, Blanche S, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics. 2007;120(3):e622\u20138.","journal-title":"Pediatrics"},{"issue":"1","key":"317_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20462","volume":"81","author":"T Henzan","year":"2006","unstructured":"Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81(1):59\u201361.","journal-title":"Am J Hematol"},{"issue":"3","key":"317_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bjh.12386","volume":"162","author":"D Chellapandian","year":"2013","unstructured":"Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013;162(3):376\u201382.","journal-title":"Br J Haematol"},{"issue":"3","key":"317_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12185-013-1419-4","volume":"98","author":"S Imashuku","year":"2013","unstructured":"Imashuku S, Kudo N, Kubo K, Yachie A. Are regimens containing rituximab effective in the initial treatment of Epstein\u2013Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis? Int J Hematol. 2013;98(3):375\u20137.","journal-title":"Int J Hematol"},{"issue":"6","key":"317_CR22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2141.2005.05694.x","volume":"130","author":"M Ando","year":"2005","unstructured":"Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, et al. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Br J Haematol. 2005;130(6):860\u20138.","journal-title":"Br J Haematol"},{"issue":"1","key":"317_CR23","first-page":"1","volume":"62","author":"M Jinta","year":"2015","unstructured":"Jinta M, Imadome K, Komatsu H, Yoshimori M, Kurata M, Fujiwara S, et al. L-Asparaginase monotherapy for EBV-positive T\/NK lymphoproliferative diseases: a pilot study. J Med Dent Sci. 2015;62(1):1\u20139.","journal-title":"J Med Dent Sci"},{"issue":"9","key":"317_CR24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.21795","volume":"85","author":"JS Ahn","year":"2010","unstructured":"Ahn JS, Rew SY, Shin MG, Kim HR, Yang DH, Cho D, et al. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2010;85(9):719\u201322.","journal-title":"Am J Hematol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-016-0317-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:06:08Z","timestamp":1601071568000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-016-0317-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s13045-016-0317-7","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]},"article-number":"84"}}